Imaging Study of Brain Dopamine Transporter Imaging Agent ~(99)Tc~m-Trodat-1

Jia Shao-wei,Shi Jie,gao zhou
2003-01-01
Abstract:Objective To study the biodistribution and imaging conditions of 99Tcm-2β-[N,N′-bis(2-mercaptoethyl) ethylenediamino] methyl, 3β-(4-chlorophenyl) tropane (TRODAT-1) dopamine transporter (DAT) in human body. Methods 925 MBq/ml 99Tcm-TRODAT-1 with radiochemical purity(Rp)85% was injected i.v. to 13 volunteers. Dynamic, whole body and tomographic imaging were performed in all the subjects. Results The 99Tcm-TRODAT-1 was bolus injected intravenously, it was stabilized in the brain after 2 min. The radioactivity distribution of 99Tcm-TRODAT-1 in brain, liver, stomach and intestines, lung, myocardium, kidney, gall bladder, thyroid gland were (1.91±0.43) %ID, (27.60±11.15) %ID, (14.13±2.24) %ID, (11.90±1.67) %ID, (4.62±0.98) %ID, (3.21±1.10) %ID, (2.37±0.67) %ID, (0.50±0.07) %ID, respectively. Most of radioactivity was in soft tissue, about (32.00±11.32) %ID. 99Tcm-TRODAT-1 was mainly eliminated by digestive system and also through kidney. Tomographic imaging showed that the corpus striatum and brain tissue have good contrast 150~170 min later. Conclusion 99Tcm-TRODAT-1 injection reached the criterion for clinical use.
What problem does this paper attempt to address?